Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (1044) Embeda (morphine sulfate and naltrexone hydrochloride), King Pharmaceuticals,
...Newly Approved Drug Therapies (1044) Embeda (morphine sulfate and naltrexone hydrochloride), King Pharmaceuticals, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Embeda (morphine sulfate and naltrexone hydrochloride) Company: King Pharmaceuticals Approval Status: Approved August of 2009 Treatment Area: moderate to severe ...
View Page

2.  Newly Approved Drug Therapies (441) Naltrexone Hydrochloride Tablets, Barr Laboratories,
...Newly Approved Drug Therapies (441) Naltrexone Hydrochloride Tablets, Barr Laboratories, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Naltrexone Hydrochloride Tablets Company: Barr Laboratories Approval Status: Approved May 1998 Treatment Area: alcohol dependence General ...
View Page

3.  CenterWatch: New Medical Therapies in Disease Category (188), Substance Abuse
...Psychology April 11, 2005 Alkermes reported positive results of a phase III trial of Vivitrex (naltrexone long-acting injection), for the treatment of alcohol dependence. Data met their primary endpoint, producing ...
...Sciences reported positive results from a phase III trial investigating a sustained release formulation of Naltrexone Depot for the treatment of alcoholism. Results showed that after six months of treatment with ...
View Page

4.  Study Posting (1024) Trial #83067, Alcohol Dependence, Boston, MA
...to the above, you may qualify for a neuroimaging research study examining the effects of naltrexone, a new treatment for alcoholism. Subjects will be compensated for their time. Boston University Medical ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (219), Addictions
...day pre-treatment regimen of the drug failed to attenuate withdrawal symptoms produced by administering naltrexone (an opioid receptor blocker) to methadone-maintained subjects. Safety results yielded a positive overall profile, and there was no indication of safety concerns resulting from interaction between Tetrodin and naltrexone. This double-blind, placebo-controlled study enrolled 14 subjects on stable methadone therapy, who received ...
View Page

6.  CenterWatch: New Medical Therapies in Disease Category (9), Alcohol Dependence
...2005 Alkermes announced positive results of a 12-month phase III extension study of Vivitrex (naltrexone long-acting injection) , for the treatment of alcohol dependence, at the Annual Meeting of the ...
...months. April 11, 2005 Alkermes reported positive results of a phase III trial of Vivitrex (naltrexone long-acting injection), for the treatment of alcohol dependence. Data met their primary endpoint, producing ...
View Page

7.  CenterWatch: Neurology Approved Drug Therapies
...zolpidem tartrate) ; Orexo; For the treatment of insomnia, Approved March 2009 Embeda (morphine sulfate and naltrexone hydrochloride) ; King Pharmaceuticals; For the treatment of moderate to severe pain, Approved August of 2009 ...
...for Epilepsy, Approved August 1998 Maxalt ; Merck; Acute treatment of migraine headache, Approved June 1998 Naltrexone Hydrochloride Tablets ; Barr Laboratories; Generic equivalent of Revia, Approved May 1998 Oxycodone and Aspirin ; Watson ...
View Page

8.  Study Posting (4971) Trial #161600, Alcohol Dependence, Maitland, FL
...carbamazepine, disulfiram, divalproex sodium, ethosuximide, felbamate, gabapentin, lamotrigine, levetiracetam, levomethadyl acetate (LAAM), mephobarbital, methadone, methsuximide, naltrexone (any formulation), ondansetron, oxcarbazepine, phenobarbital, primidone, tiagabine, topiramate, valproate sodium, valproic acid, and zonisamide. Traci ...
View Page

9.  Study Posting (4265) Trial #163387, Alcohol Dependence, West Palm Beach, FL
...randomization • Current or anticipated need for prescribed opioid medication during the study period • Use of naltrexone (including VIVITROL) within 60 days prior to screening • Major depression with suicidal ideation, psychosis, bipolar ...
View Page

10.  CenterWatch Clinical Research Profile (5214) Trial #2133, Granger Medical Research, West Valley City, UT
...Diabetic Foot Ulcers • Pain Management • OraVescent Fentanyl Citrate for breakthrough pain • D-Trans Fentanyl with Naltrexone HCI • Non-Opioid Patch for Tendonitis/Bursitis pain control • Migraine Headache • Acute, Painful Musculoskeletal Spasm ...
View Page

11.  CenterWatch: New Medical Therapies in Disease Category (45), Chronic Pain
...2005 Pain Therapeutics has reported mixed results of a phase III trial of Oxytrex (oxycodone/naltrexone), their mixed opioid agonist/antagonist for the treatment of chronic pain. Trial data exceeded their ...
...10 mg four times daily Oxytrex; 10 mg four times daily oxycodone, ultra-low-dose naltrexone, or placebo). October 31, 2005 LAB International announced positive results of a phase I trial ...
View Page

12.  CenterWatch: Psychiatry/Psychology Approved Drug Therapies
...Attention Deficit Disorder, Approved October 1998 Marplan Tablets ; Roche; Treatment of Depression, Approved August 1998 Naltrexone Hydrochloride Tablets ; Barr Laboratories; Generic equivalent of Revia, Approved May 1998 Prochlorperazine ; IVAX; Generic equivalent ...
View Page

13.  CenterWatch: List of Newly Approved Drug Thearapies
...for Epilepsy, Approved August 1998 Maxalt ; Merck; Acute treatment of migraine headache, Approved June 1998 Naltrexone Hydrochloride Tablets ; Barr Laboratories; Generic equivalent of Revia, Approved May 1998 Oxycodone and Aspirin ; Watson ...
...Attention Deficit Disorder, Approved October 1998 Marplan Tablets ; Roche; Treatment of Depression, Approved August 1998 Naltrexone Hydrochloride Tablets ; Barr Laboratories; Generic equivalent of Revia, Approved May 1998 Prochlorperazine ; IVAX; Generic equivalent ...
View Page

14.  CenterWatch: List of Newly Approved Drug Thearapies
...zolpidem tartrate) ; Orexo; For the treatment of insomnia, Approved March 2009 Embeda (morphine sulfate and naltrexone hydrochloride) ; King Pharmaceuticals; For the treatment of moderate to severe pain, Approved August of 2009 ...
View Page

15.  Study Posting (5184) Trial #156468, Pain, Chicago, IL
...study. • Known or suspected allergy to opioids, opioid derivatives, or opioid antagonists ( e.g.,codeine, naltrexone, or naloxone) or other compounds related to these classes of medications. • Current treatment with partial ...
View Page

16.  CenterWatch: New Medical Therapies in Disease Category (90), Irritable Bowel Syndrome (IBS)
...2003 Pain Therapeutics reported positive results from a phase I/II trial investigating PTI-901 (naltrexone) , an opioid antagonist for the treatment of irritable bowel syndrome (IBS). Results showed a response ...
View Page

17.  CenterWatch: New Medical Therapies in Disease Category (107), Obesity
...trial, dubbed NB-302 enrolled 793 subjects in the US. The subjects received Contrave (32mg naltrexone SR/360mg bupropion SR) or placebo, in combination with intense diet, exercise and behavior modification ...
View Page